Injective (INJ) Gains Momentum on Robinhood Listing and Coinbase Mainnet Migration

Key Facts

1Injective's INJ token has been listed on Robinhood, expanding retail investor access.

2Coinbase has commenced its mainnet migration for the Injective protocol.

3Injective unveiled regulatory and ecosystem updates at its summit in Washington.

In a move reflecting growing institutional adoption of decentralized finance protocols, Robinhood has listed Injective's INJ token, significantly expanding access for retail investors. Simultaneously, Coinbase has commenced its mainnet migration for the Injective protocol, a critical technical milestone for liquidity. Furthermore, Injective unveiled key regulatory and ecosystem updates during its summit in Washington to bolster the network's long-term growth.

This expansion occurs as major trading platforms show robust performance; market data indicates Robinhood (HOOD) has maintained strong valuation levels as exchanges compete to offer high-utility digital assets. Compared to previous quarters, industry analysts suggest that INJ's integration into major platforms strengthens its competitive position against other Layer-1 protocols, especially as capital continues to flow into blockchain-based financial solutions per market reports.

Regarding market performance, HOOD shares closed at $106.02 (close July 16, 2026), having traded between a low of $105.48 and a high of $114.52. Traders are now monitoring broader US economic catalysts that influence risk appetite, noting that the Consumer Price Index (CPI) data released on July 14, 2026, showed annual inflation cooling to 3.5%, which may support sustained momentum for digital assets and related equities.